Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Untitled story (opens in a new tab)

eurekalert.org · 2023-04-03

Short answerEvidenceSource

Short answer

Mixed

Mixed.

2 claims go further than the study. 2 other points were not covered by the paper.

  • 2 supported
  • 2 overstated
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Two of six claims overstate the study. Two of six check out. Two claims the study doesn't address.

  • 2 supported
  • 2 overstated
  • 2 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6OverstatedCold activates a cellular cleansing mechanism that breaks down harmful protein aggregations responsible for various diseases associated with aging.View evidenceHide evidence

Why this verdict

The abstract supports a causal model-system finding that cold activates PA28γ/PSME-3/PSME3-dependent proteasome trypsin-like activity and reduces disease-related aggregation in C. elegans and human cell models. But the headline frames this broadly as harmful aggregations responsible for various aging diseases being broken down, without the model-system and disease-scope limits; the headline therefore outruns the evidence and the story body’s more specific framing.

1

Study evidence

Cold exposure (15 °C) selectively induces proteasome trypsin-like activity in C. elegans via PSME-3 (psme-3).

“cold temperature (15 °C) selectively induces the trypsin-like activity of the proteasome in Caenorhabditis elegans through PSME-3”
2

Study evidence

Cold exposure (15 °C) reduces disease-related protein aggregation in C. elegans models of Huntington's disease and ALS; this anti-aggregation effect is associated with and depends on the proteasome activator PSME-3/PA28γ.

“cold-induced PA28γ/ PSME-3 diminishes protein aggregation in C. elegans models of age-related diseases such as Huntington's and amyotrophic lateral sclerosis.”
Claim 2 of 6OverstatedThe study used the nematode Caenorhabditis elegans and cultivated human cells carrying genes for ALS and Huntington’s disease, and in both model systems cold actively removed protein clumps and prevented pathological protein aggregation.View evidenceHide evidence

Why this verdict

The paper profile supports use of C. elegans Huntington’s/ALS proteinopathy models and human cell models, and supports cold-associated reduction of disease-related protein aggregation in both settings. However, the story’s wording that cold 'actively removed' clumps and 'prevented' pathological aggregation is stronger than the abstract evidence, which says aggregation was reduced/diminished, not fully prevented or necessarily cleared.

1

Study evidence

Cold exposure (15 °C) reduces disease-related protein aggregation in C. elegans models of Huntington's disease and ALS; this anti-aggregation effect is associated with and depends on the proteasome activator PSME-3/PA28γ.

“cold-induced PA28γ/ PSME-3 diminishes protein aggregation in C. elegans models of age-related diseases such as Huntington's and amyotrophic lateral sclerosis.”
2

Study evidence

Moderate cold exposure (36 °C) activates proteasome trypsin-like activity in human cells via PA28γ/PSME3.

“exposure of human cells to moderate cold temperature (36 °C) also activates trypsin-like activity through PA28γ/PSME3, reducing disease-related protein aggregation and neurodegeneration.”
Claim 3 of 6Not coveredThe researchers say the proteasome activator PA28γ/PSME3 mitigated age-related deficits, and that proteasome activity could be increased either by a moderate decrease in temperature or by genetic overexpression of the activator.View evidenceHide evidence

Why this verdict

The abstract supports that PSME-3/PA28γ ameliorates age-related protein-degradation deficits and that moderate cold increases proteasome trypsin-like activity through PA28γ/PSME3. But the specific claim that proteasome activity could be increased by genetic overexpression of the activator is not established in the abstract-level profile with enough detail to verify.

1

Study evidence

Cold exposure (15 °C) selectively induces proteasome trypsin-like activity in C. elegans via PSME-3 (psme-3).

“cold temperature (15 °C) selectively induces the trypsin-like activity of the proteasome in Caenorhabditis elegans through PSME-3”
2

Study evidence

Moderate cold exposure (36 °C) activates proteasome trypsin-like activity in human cells via PA28γ/PSME3.

“exposure of human cells to moderate cold temperature (36 °C) also activates trypsin-like activity through PA28γ/PSME3, reducing disease-related protein aggregation and neurodegeneration.”
Claim 4 of 6Not coveredThe story adds that a previous study reported human body temperature has declined by 0.03 degrees Celsius per decade since the Industrial Revolution, suggesting a possible link to rising human life expectancy.View evidenceHide evidence

As stated0.03 degrees Celsius per decade

Why this verdict

The abstract-level profile notes a general association between lowering body/environmental temperature and lifespan extension, but it does not verify the cited previous-study estimate of a 0.03 °C per decade decline in human body temperature or the proposed link to rising human life expectancy.

Claim 5 of 6SupportedA research team at the University of Cologne says it has identified one responsible mechanism for how lowered body temperature can extend longevity.View evidenceHide evidence

Why this verdict

The abstract-level profile supports that the team identified PSME-3/PA28γ-dependent proteasome activation as one mechanism required for cold-induced longevity in C. elegans. The support is strongest when read with that organismal scope; it does not establish human longevity effects.

1

Study evidence

Cold exposure (15 °C) selectively induces proteasome trypsin-like activity in C. elegans via PSME-3 (psme-3).

“cold temperature (15 °C) selectively induces the trypsin-like activity of the proteasome in Caenorhabditis elegans through PSME-3”
Claim 6 of 6SupportedThe article says these results may have therapeutic implications for aging and aging-associated diseases and may apply to other age-related neurodegenerative diseases and other animal species.View evidenceHide evidence

Why this verdict

The story frames broader therapeutic and cross-species/disease implications as speculative. That hedged framing is consistent with the abstract-level profile, which reports worm and human-cell conservation and says the findings may have implications for multiple protein-aggregation diseases, while not establishing clinical benefit.

1

Study evidence

Cold exposure (15 °C) reduces disease-related protein aggregation in C. elegans models of Huntington's disease and ALS; this anti-aggregation effect is associated with and depends on the proteasome activator PSME-3/PA28γ.

“cold-induced PA28γ/ PSME-3 diminishes protein aggregation in C. elegans models of age-related diseases such as Huntington's and amyotrophic lateral sclerosis.”
2

Study evidence

Moderate cold exposure (36 °C) activates proteasome trypsin-like activity in human cells via PA28γ/PSME3.

“exposure of human cells to moderate cold temperature (36 °C) also activates trypsin-like activity through PA28γ/PSME3, reducing disease-related protein aggregation and neurodegeneration.”
Then look for missing context

Context layer

What the story carried across

Nothing material from the study was dropped.

4 things the story did carry across
  • Cold exposure at 15 °C in C. elegans selectively induces proteasome trypsin-like activity through PSME-3, and PSME-3 is required for cold-induced lifespan extension and improved age-related protein degradation/proteostasis.
  • Cold-induced PA28γ/PSME-3 diminishes disease-related protein aggregation in C. elegans models of Huntington’s disease and ALS.
  • Moderate cold exposure at 36 °C in human cell culture activates PA28γ/PSME3-dependent proteasome trypsin-like activity and reduces disease-related aggregation/neurodegeneration-related cellular phenotypes.
  • The evidence is basic research in C. elegans and human cell culture, not clinical evidence that cold exposure or PA28γ/PSME3 manipulation treats human aging-associated disease or extends human lifespan.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

in vivo animal

1Lead resultin vivo animalCold temperature extends longevity in C. elegans via PA28γ/PSME-3–dependent induction of proteasome trypsin-like activity and improved proteostasis with age.in vivo animalExpand

In plain English

In Caenorhabditis elegans, exposure to cold temperature (15 °C) selectively induces proteasome trypsin-like activity via PSME-3 (psme-3). PSME-3 is reported as required for the lifespan extension caused by cold and for amelioration of age-related deficits in protein degradation; cold-induced PSME-3 also reduces protein aggregation in C. elegans models of Huntington's disease and amyotrophic lateral sclerosis.

Key findings

  • Cold exposure (15 °C) selectively induces proteasome trypsin-like activity in C. elegans via PSME-3 (psme-3).
  • PSME-3 (psme-3) is required for cold-induced longevity in C. elegans.
“cold temperature (15 °C) selectively induces the trypsin-like activity of the proteasome in Caenorhabditis elegans through PSME-3”
What this piece can’t prove
  • The abstract does not specify the exact genetic approach used to test psme-3 requirement (e.g., alleles, RNAi), nor off-target/control experiments.
  • Generality beyond the reported C. elegans experiments (e.g., translatability) is not assessed within this unit focused on worm data.

2 further details could not be confirmed from the summary.

2in vivo animalCold-induced PA28γ/PSME-3 reduces disease-related protein aggregation in C. elegans models of neurodegenerative proteinopathies (for example Huntington’s and ALS models).in vivo C elegans disease modelsExpand

In plain English

In C. elegans models of age-related neurodegenerative proteinopathies (Huntington's disease and ALS models), exposure to cold temperature (15 °C) reduces disease-related protein aggregation. The cold effect is linked to induction of the proteasome activator PSME-3 (worm orthologue of human PA28γ), and PSME-3/PA28γ is implicated as required for the cold-associated anti-aggregation/proteostasis benefits.

Key findings

  • Cold exposure (15 °C) reduces disease-related protein aggregation in C. elegans models of Huntington's disease and ALS; this anti-aggregation effect is associated with and depends on the proteasome activator PSME-3/PA28γ.
“cold-induced PA28γ/ PSME-3 diminishes protein aggregation in C. elegans models of age-related diseases such as Huntington's and amyotrophic lateral sclerosis.”
What this piece can’t prove

3 further details could not be confirmed from the summary.

3in vitroModerate cold exposure activates PA28γ/PSME3-dependent proteasome trypsin-like activity in human cells and reduces disease-related protein aggregation/neurodegeneration, suggesting evolutionary conservation.in vitro human cell culture moderate-cold exposureExpand

In plain English

In human cell culture, exposure to moderate cold (36 °C) activates proteasome trypsin-like activity through PA28γ/PSME3, and this PA28γ-dependent activation is reported to reduce disease-related protein aggregation and neurodegeneration-related cellular phenotypes in cell-based models.

Key findings

  • Moderate cold exposure (36 °C) activates proteasome trypsin-like activity in human cells via PA28γ/PSME3.
  • PA28γ/PSME3-dependent activation induced by moderate cold reduces disease-related protein aggregation and neurodegeneration-related cellular phenotypes in human cell models.
“exposure of human cells to moderate cold temperature (36 °C) also activates trypsin-like activity through PA28γ/PSME3, reducing disease-related protein aggregation and neurodegeneration.”
What this piece can’t prove

3 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Crossref, Europe PMC · 15 candidate papers

And 9 more candidates considered.